These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 16574043
1. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane. Taylor PW, Keenan MH. Curr Med Res Opin; 2006 Mar; 22(3):603-15. PubMed ID: 16574043 [Abstract] [Full Text] [Related]
2. Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation? Smith JC, Tarocco G, Merazzi F, Salzmann U. Curr Med Res Opin; 2006 Apr; 22(4):709-20. PubMed ID: 16684432 [Abstract] [Full Text] [Related]
3. Are we underdosing acne patients with generic isotretinoin? Mutizwa MM, Sheinbein DM. Dermatol Online J; 2013 Jan 15; 19(1):12. PubMed ID: 23374954 [Abstract] [Full Text] [Related]
4. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. J Am Acad Dermatol; 2001 Aug 15; 45(2):196-207. PubMed ID: 11464180 [Abstract] [Full Text] [Related]
5. Comparison of simvastatin tablets from the US and international markets obtained via the Internet. Veronin MA, Nguyen NT. Ann Pharmacother; 2008 May 15; 42(5):613-20. PubMed ID: 18413690 [Abstract] [Full Text] [Related]
6. Oral isotretinoin for acne, adjusting treatment according to patient's response. Ghaffarpour G, Mazloomi S, Soltani-Arabshahi R, Seyed KS. J Drugs Dermatol; 2006 Oct 15; 5(9):878-82. PubMed ID: 17039654 [Abstract] [Full Text] [Related]
7. Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®. Gasser UE, Fischer A, Timmermans JP, Arnet I. BMC Pharmacol Toxicol; 2013 Apr 23; 14():24. PubMed ID: 23617953 [Abstract] [Full Text] [Related]
8. Pharmaceutical quality of nine generic orlistat products compared with Xenical(r). Taylor PW, Arnet I, Fischer A, Simpson IN. Obes Facts; 2010 Aug 23; 3(4):231-7. PubMed ID: 20823686 [Abstract] [Full Text] [Related]
9. Roche responds to 'new warnings on the use of isotretinoin (Roaccutane)'. Ebrahim O, Bredenhann M. S Afr Med J; 1999 Jan 23; 89(1):16. PubMed ID: 10070397 [No Abstract] [Full Text] [Related]
10. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients. Liu A, Yang DJ, Gerhardstein PC, Hsu S. J Drugs Dermatol; 2008 Oct 23; 7(10):963-6. PubMed ID: 19112761 [Abstract] [Full Text] [Related]
11. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Kaymak Y, Taner E, Taner Y. Int J Dermatol; 2009 Jan 23; 48(1):41-6. PubMed ID: 19126049 [Abstract] [Full Text] [Related]
12. Accutane-exposed pregnancies--California, 1999. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2000 Jan 21; 49(2):28-31. PubMed ID: 10680601 [Abstract] [Full Text] [Related]
13. Isotretinoin: state of the art treatment for acne vulgaris. Ganceviciene R, Zouboulis CC. J Dtsch Dermatol Ges; 2010 Mar 21; 8 Suppl 1():S47-59. PubMed ID: 20482692 [Abstract] [Full Text] [Related]
14. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin. Lambert PA, Conway BR. J Chemother; 2003 Aug 21; 15(4):357-68. PubMed ID: 12962364 [Abstract] [Full Text] [Related]
15. Comparison of pharmaceutical quality of eight generic ganciclovir injections in China and Cymevene. Hong C, Wang J. J Chemother; 2018 Sep 21; 30(5):310-315. PubMed ID: 30843773 [Abstract] [Full Text] [Related]
16. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. Layton AM, Dreno B, Gollnick HP, Zouboulis CC. J Eur Acad Dermatol Venereol; 2006 Aug 21; 20(7):773-6. PubMed ID: 16898895 [Abstract] [Full Text] [Related]
17. Impurities in generic pharmaceutical development. Kovaleski J, Kraut B, Mattiuz A, Giangiulio M, Brobst G, Cagno W, Kulkarni P, Rauch T. Adv Drug Deliv Rev; 2007 Jan 10; 59(1):56-63. PubMed ID: 17196702 [Abstract] [Full Text] [Related]
18. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications. Maddineni J, Walenga JM, Jeske WP, Hoppensteadt DA, Fareed J, Wahi R, Bick RL. Clin Appl Thromb Hemost; 2006 Jul 10; 12(3):267-76. PubMed ID: 16959680 [Abstract] [Full Text] [Related]
19. [The Medical Products Agency is following up Roaccutane to assure patients' safety]. Gerdén B, Sjölin-Forsberg G, Trolin I. Lakartidningen; 2003 Mar 06; 100(10):870. PubMed ID: 12680028 [No Abstract] [Full Text] [Related]
20. Analysis of purity profiles of generic lisinopril tablets marketed in Croatia. Benković G, Sokolić M, Cudina B, Zulj RT, Tomić S. Coll Antropol; 2013 Jun 06; 37(2):601-6. PubMed ID: 23941010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]